ST JUDE MEDICAL, LLC 4
4 · ST JUDE MEDICAL, LLC · Filed Jan 6, 2017
Insider Transaction Report
Form 4
DVORAK DAVID C
Director
Transactions
- Disposition to Issuer
Common Stock
2017-01-04−5,599→ 0 total
Footnotes (1)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories ("Abbott"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the "Merger Agreement"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the "Merger Consideration"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock.